|
ALDH1B1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.65120000000086E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.06919995079835E-09 |
| Normal-vs-Stage2 |
5.218700E-04 |
| Normal-vs-Stage3 |
2.960300E-02 |
| Normal-vs-Stage4 |
2.180600E-03 |
| Stage1-vs-Stage2 |
7.081200E-01 |
| Stage1-vs-Stage3 |
1.196220E-01 |
| Stage1-vs-Stage4 |
8.655400E-01 |
| Stage2-vs-Stage3 |
2.790200E-01 |
| Stage2-vs-Stage4 |
7.035800E-01 |
| Stage3-vs-Stage4 |
2.942800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.50619999999791E-05 |
| Normal-vs-AfricanAmerican |
5.4157999995752E-07 |
| Normal-vs-Asian |
3.963400E-01 |
| Caucasian-vs-AfricanAmerican |
3.942300E-02 |
| Caucasian-vs-Asian |
7.936000E-01 |
| AfricanAmerican-vs-Asian |
6.213400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.84039999801189E-08 |
| Normal-vs-Female |
5.562700E-03 |
| Male-vs-Female |
3.699800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.732400E-02 |
| Normal-vs-Extreme_Weight |
8.44830000401586E-08 |
| Normal-vs-Obese |
1.41239999995602E-06 |
| Normal-vs-Extreme_Obese |
4.663000E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.210400E-01 |
| Normal_Weight-vs-Obese |
3.713200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.411200E-01 |
| Extreme_Weight-vs-Obese |
8.352200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.713000E-01 |
| Obese-vs-Extreme_Obese |
9.617000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.402500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.241990E-04 |
| Normal-vs-Age(61-80Yrs) |
1.89829999996949E-06 |
| Normal-vs-Age(81-100Yrs) |
8.218300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.606800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.743200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.163000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.506400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.536800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.273200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.76610000002242E-06 |
| Normal-VS-Type2 PRCC |
1.588150E-01 |
| Normal-VS-KIRP CIMP |
1.550130E-02 |
| Normal-VS-Unclassified PRCC |
1.60010000005428E-06 |
| Type1 PRCC-VS-Type2 PRCC |
4.24170000000723E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.667200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.528600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.396800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.995600E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
4.231200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.253800E-01 |
| Normal-vs-N1 |
1.410160E-04 |
| Normal-vs-N2 |
1.51150000005096E-06 |
| N0-vs-N1 |
4.300400E-02 |
| N0-vs-N2 |
1.303420E-03 |
| N1-vs-N2 |
3.882000E-01 |
|
|
